| Ytd | 95.61% | |
| 1y | 202.17% |
| Open | 22.72 | Prev Close | 22.67 | Low | 22.19 | High | 23.73 | Mkt Cap | 2.63B |
| Vol | 0.00 | Avg Vol | 1.66M | EPS | -1.50 | P/E | -15.75 | Forward P/E | -16.47 |
| Beta | -0.20 | Short Ratio | 6.93 | Inst. Own | 105.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 17.43 | 200-d Avg | 15.05 | 1yr Est | 28.33 |
Vertex Pharmaceuticals, Amylyx Pharmaceuticals, Praxis Precision Medicines and BridgeBio Pharma face
Bank of New York Mellon Corp raised its stake in Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) by 15.5
Amylyx Pharmaceuticals (AMLX) is transitioning from its ALS legacy to a late-stage endocrine company
Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript
Amylyx Pharmaceuticals NASDAQ: AMLX said its pivotal Phase III LUCIDITY trial of avexitide in post-b
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports Second Quarter 2026 Fina
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Report Second Quarter 2026 Fi
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Present Data from First-in-Hu
Amylyx Pharmaceuticals NASDAQ: AMLX Co-Chief Executive Officer Justin Klee said the company is prepa
Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen
[url="]Amylyx Pharmaceuticals, Inc.[/url] (NASDAQ: AMLX) (âAmylyxâ or the âCompanyâ) today a
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Announces Poster Presentations a
BOSTON, June 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Co
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Com
Amylyx Pharmaceuticals NASDAQ: AMLX is preparing for a pivotal Phase 3 readout for AVEXITIDE, its le
Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Bank of America Global Healthcare Conference 2026 Tr
Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2026 Earnings Call Transcript
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports First Quarter 2026 Finan
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Com
Amylyx Pharmaceuticals (NASDAQ: AMLX) is entering what it described as a pivotal year for its lead p
US stock futures higher with Dow up 200 pts, Beyond Meat shares drop after downbeat results; ORIC, R
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the co
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
On Tuesday, 647 companies set new 52-week lows.
During Tuesday's session, 275 companies made new 52-week lows.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The compan
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tu
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
Upgrades
On Monday, 147 stocks hit new 52-week lows.
Gainers
Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday